DecisionHealth, DecisionHealth - 2010 Issue 6 (June)

Part B drug prices suffer an overall decrease despite 280 price increases

Overall drug prices on the Part B Average Sales Price (ASP) list will tumble next quarter, CMS says. Prices will decrease by 0.7% despite a Part B News analysis of the ASP plus 6% payment system that shows a majority of the individual drugs will see price increases. The introduction of generics caused some drug prices to drop by 20% or more and brought down the rest of the list, CMS says.

To read the full article, sign in and subscribe to the DecisionHealth Newsletters.

Thank you for choosing Find-A-Code, please Sign In to remove ads.